Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.
Compare providers & treatments
Compare GLP-1 Programs, Clinics & Peptide Treatments
Ranked roundups and side-by-side guides that show how providers handle pricing, access, and clinical oversight, so you can shortlist with confidence. Informational only, not medical advice.
Best Online GLP-1 Programs
Our most-used comparison: the online GLP-1 programs ranked by clinical review, pricing clarity, delivery, and support.
- Ranked on clinical review, pricing clarity, and follow-up support
- Brand-name and compounded pathways compared side by side
- What each program includes before you check eligibility
Start with a ranked roundup
If you're not comparing two specific names yet, these editorial rankings are the fastest way to see the field.
Brand-Name GLP-1 Cash Prices (US)
FDA approved brand-name GLP-1 medicines priced by seller: the manufacturers' self-pay programs beside telehealth, read daily from each page.
Read the rankingRanked guideBest Online Weight-Loss Clinics
Ranked by clinical review, GLP-1 access, support, pricing, and delivery.
Read the rankingRanked guideGLP-1 Providers
A neutral overview of GLP-1 provider options and next steps.
Read the rankingRanked guideSemaglutide Providers
Semaglutide provider options and the clinic pathways behind them.
Read the rankingOnline GLP-1 & weight-loss programs · 25
Head-to-head guides on the telehealth programs people weigh up most: support model, pricing, and how each handles access.
Both are popular online GLP-1 providers, but Eden is usually the simpler starting point while Ro is the more recognisable consumer-health brand.
CompareEden is the simpler option for most users, while Fridays is better suited to people who want a more support-led program.
CompareEden is the stronger all-round starting point, while MEDVi is the more cost-conscious option to benchmark when entry pricing matters most.
CompareEden is the stronger premium-support starting point, while Shed is better for needle-averse cash-pay users who want a GLP-1 lozenge option and a results guarantee.
CompareRo is the better fit for users who value a familiar health brand, while Fridays is stronger for users who want more guidance and follow-up structure.
CompareFridays is more support-led, while MEDVi is the simpler affordability comparison for users focused on a lower entry point.
CompareEmbody advertises compounded semaglutide at $49 a month and tirzepatide at $99 a month, a sale price fixed per medication (checked November 19, 2026), while Fridays is the more support-led program and its price is one to confirm directly.
CompareEmbody advertises compounded semaglutide at $49 a month and tirzepatide at $99 a month, a sale price with no membership fee (checked November 19, 2026), while Ro sells a membership plus brand-name medication billed separately.
CompareEmbody advertises compounded semaglutide at $49 a month and tirzepatide at $99 a month, a sale price with no membership fee (checked November 19, 2026), while MEDVi lists compounded GLP-1 injections at an introductory $99 for the first month, with refills at $199, and publishes its partner pharmacies and refund terms.
CompareCompare Eden and Strut Health for online GLP-1 and weight-management care.
CompareEmbody or Gala Health? Independent comparison of entry pricing, support between refills and intake speed — plus what to confirm before starting either.
CompareHims vs Ro: both cost $188 for month one and $298/mo after at the starting dose; Ro's prepaid plan cuts it to $223/mo. Checked Nov 19, 2026.
CompareTrimRx vs MEDVi: GLP-1 from $89 at TrimRx against an introductory $99 first month then $199 refills at MEDVi (checked Nov 19, 2026), plus pharmacies, refunds and each public record.
CompareTrimRx vs Ro: compounded GLP-1 from $89 all-in at TrimRx against Ro's membership plus brand-name medication, $298/mo at the starting dose (checked Nov 19, 2026). Refunds, insurance and public record.
CompareEmbody vs TrimRx: compounded semaglutide $49 and tirzepatide $99 a month at Embody against GLP-1 from $89 at TrimRx (checked Nov 19, 2026). Pharmacies, refunds and each public record.
CompareHims vs MEDVi: Hims is a $149 membership plus brand-name medication, $298/mo at the lowest price; MEDVi is compounded GLP-1 at an introductory $99 then $199 refills (checked Nov 19, 2026).
CompareShed vs MEDVi: Shed's compounded GLP-1 plans by commitment length, against MEDVi's introductory $99 then $199 refills (checked Nov 19, 2026). Minimum terms, refunds, states.
CompareRo vs Noom for GLP-1s: Ro's membership plus brand-name medication, $298/mo at the starting dose, against Noom's Microdose GLP-1Rx from $79, then $179/mo with medication (checked Nov 19, 2026).
CompareRo vs Mochi Health: Ro $298/mo with brand-name medication at the starting dose; Mochi a $79/mo membership plus compounded semaglutide from (checked Nov 19, 2026). Fees, refunds, record.
CompareRo vs MEDVi: Ro is a $149 membership plus brand-name medication, $298/mo at the starting dose; MEDVi is compounded GLP-1 at an introductory $99 then $199 refills (checked Nov 19, 2026).
CompareA factual price and process comparison of Embody and welludr, two online programs that dispense compounded medication. Everything on this page comes from each provider's own site, with the date each price was checked shown beside it, and where a detail is not stated on a site, this page says so rather than guessing.
CompareCompare welludr and Ro for weight loss on price, medicines, how each bills and who each suits, using only what our own reviews record and the dates they were checked. welludr dispenses compounded medication, which is not FDA approved, while Ro lists brand-name options.
CompareCompare welludr and MEDVi on price, medicines, pharmacies, cancellation and regulatory record, using only what our own reviews record and the dates they were checked. Where a detail is not stated on a site, this page says so.
CompareCompare welludr and Fridays Health on price, medicines, support and availability, using only what our own reviews record and the dates they were checked. Prices are dated from our daily price read; where a figure is not held, the page says so.
CompareEden vs Embody: compounded semaglutide $99 and tirzepatide $129 a month at Eden, $49 and $99 at Embody (checked November 19, 2026). Plans and who each suits.
CompareGLP-1 & weight-loss medications · 13
How the main GLP-1 and weight-loss medications are positioned across clinics: access models, monitoring, and prescriber oversight.
Both are Russian-developed peptides registered as medicines in Russia but unapproved in the US and UK. Selank is positioned around anxiety, Semax around cognition and stroke recovery — with evidence bases that largely predate Western-standard trials.
CompareTirzepatide is an approved, prescribable medicine; retatrutide is still investigational with no approved product anywhere. That access difference — not trial percentages — is the practical distinction for anyone comparing the two today.
CompareSemaglutide is an approved, prescribable medicine available today; cagrilintide is investigational. That difference — not trial percentages — is the practical distinction in 2026.
CompareTirzepatide is an approved, prescribable medicine; survodutide is a glucagon/GLP-1 dual agonist still in Phase 3. Anyone offered 'survodutide' today is being offered an unapproved product.
CompareBoth are common topics in weight-management category pages. Use clinic profiles to compare communication quality, monitoring process, and practical access details.
CompareSemaglutide is associated with weight management pathways while sermorelin appears in hormone optimization and longevity contexts. Use clinic profiles to compare service scope and clinician oversight.
CompareTirzepatide targets GLP-1 and GIP receptors for metabolic health while sermorelin is a growth hormone secretagogue used in longevity protocols. Compare clinic listings by treatment focus and governance model.
CompareBoth are GLP-1 medications referenced in weight-management listings. Compare provider oversight, monitoring, and access models.
CompareOzempic and Wegovy are brand names for semaglutide in different clinical contexts. Compare clinic prescribing models and monitoring.
CompareUS cash prices by seller, read daily, beside the head-to-head trial result, FDA approved uses, pill or pen and side effects.
CompareLilly's daily pill against its weekly injection: US cash prices by seller, read daily, beside each one's trial results and how it is taken.
CompareThe daily tablet against the weekly pen: US cash prices by seller, read daily, beside how each is taken and each one's trial results.
CompareThe same tirzepatide under two brands: each one's FDA approved uses, forms and dose steps, with US cash prices by seller, read daily.
CompareRecovery & repair peptides · 4
Peptides commonly listed in recovery, injury, and tissue-repair clinic protocols.
Both topics are often associated with recovery-focused clinic listings. Compare provider transparency, consultation model, and follow-up structure.
CompareBoth peptides appear in recovery and regenerative medicine clinic listings. BPC-157 is associated with injury recovery while GHK-Cu is frequently referenced in skin and tissue repair contexts.
CompareTB-500 and GHK-Cu appear in different clinic contexts: recovery pathways versus skin and tissue support. Compare provider focus and monitoring standards.
CompareBPC-157 and ipamorelin appear in different clinic contexts: recovery pathways versus hormone optimization. Compare provider focus and oversight.
CompareGrowth hormone & hormone optimization · 7
Growth hormone secretagogues and hormone-optimization options frequently paired together in clinic listings.
Both are growth hormone secretagogues frequently listed together in clinic protocols. Compare provider transparency, consultation model, and follow-up structure.
CompareBoth are growth hormone-releasing peptides used in hormone optimization and longevity clinic contexts. Compare clinic profiles by protocol transparency and clinician oversight.
CompareBoth are referenced as growth hormone secretagogues in performance and longevity clinic listings. MK-677 is orally active while ipamorelin is typically injectable. Compare clinic listings by service scope and monitoring protocols.
CompareHGH and sermorelin are referenced in hormone optimization and longevity clinic contexts. Compare provider governance, consultation depth, and monitoring standards.
CompareBoth appear in hormone optimization and longevity clinic listings as GH secretagogue options. Compare provider transparency and monitoring protocols.
CompareMK-677 and HGH are referenced in performance and hormone optimization contexts. Compare clinic governance, prescribing standards, and monitoring.
CompareSermorelin and tesamorelin are referenced in hormone optimization contexts. Compare clinic governance and monitoring standards.
CompareLongevity & anti-aging · 3
Compounds referenced in longevity and cellular-health protocols, often with different delivery formats.
Both are referenced in longevity and anti-aging clinic protocols. Compare clinic listings by treatment scope, consultation model, and clinician credentials.
CompareNAD+ and NMN appear in longevity clinic contexts, often with different delivery formats. Compare provider transparency and monitoring.
CompareGHK-Cu and epitalon appear in longevity and regenerative clinic contexts. Compare provider focus, protocol transparency, and oversight.
CompareNot sure which comparison you need?
Tell us your goal and we'll point you to the right providers to compare, or browse the full directory of listed clinics and programs.